Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal clinical cutoff point.

Kotha, Nikhil V; Cherry, Daniel R; Bryant, Alex K; Nalawade, Vinit; Stewart, Tyler F; Rose, Brent S

Kotha, Nikhil V; Cherry, Daniel R; Bryant, Alex K; Nalawade, Vinit; Stewart, Tyler F; Rose, Brent S.

Afiliación

Kotha NV; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA 92037, USA.
Cherry DR; Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA.
Bryant AK; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA 92037, USA.
Nalawade V; Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA.
Stewart TF; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA.
Rose BS; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA 92037, USA.

Clin Transl Radiat Oncol ; 28: 133-140, 2021 May.

Article en En | MEDLINE | ID: mdl-33997320

Palabras clave

LCS, lung cancer-specific survival; NCS, non-lung cancer survival; NLR, Neutrophil-lymphocyte ratio; NSCLC, non-small cell lung cancer; Neutrophil-lymphocyte ratio; Non-small cell lung cancer; OS, overall survival; Prognostic factors; SBRT, stereotactic body radiotherapy; Stereotactic body radiotherapy; VA, Veterans Affairs; Veterans affairs (U.S.)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Transl Radiat Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Irlanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google